Keynote: Medication for ostomates
Monday, 30 November 2026, 3:00 pm
Annika van der Linde
Annika van der Linde says that patients with an ileostomy often have altered drug absorption. Clinicians must review dosage forms and switch to better-absorbed alternatives when needed. She emphasises early detection of therapy failure and calls for structured medication reviews involving surgeons, stoma therapists and clinical pharmacists. Her approach focuses on interdisciplinary collaboration to improve medication safety for stoma carriers.
About Annika van der Linde
Annika van der Linde is a pharmacist at the Hospital Pharmacy of University Medical Center Hamburg-Eppendorf (UKE), with a particular focus on medication management in patients with an enterostomy. Her research addresses altered drug absorption after ostomy surgery and the role of clinical pharmacy in identifying and preventing medication-related problems. She will deliver the keynote on drug therapy in ostomy patients, bringing a pharmacological perspective directly into interdisciplinary colorectal care.
Care Symposium 2026
See the full program and secure your seat.
You might also be interested in
-
Stoma in IBD patients – what you should know?
Peter Kienle argues that stoma formation in inflammatory bowel disease (IBD) is not just a last resort.
-
Ileostomy vs. Colostomy: focus on different options
As Gabriela Möslein contends, selecting an appropriate stoma requires more than choosing a surgical technique.
-
Stoma care in the acute hospital – the role of nursing in education and self-management
Receiving a stoma presents those affected with numerous challenges that extend far beyond their hospital stay.